financetom
Business
financetom
/
Business
/
BRIEF-The Geo Group To Acquire Detention Facility In San Diego For $60 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-The Geo Group To Acquire Detention Facility In San Diego For $60 Million
Jul 1, 2025 4:11 AM

July 1 (Reuters) - Geo Group Inc ( GEO ):

* THE GEO GROUP ANNOUNCES IT HAS ENTERED INTO A PURCHASE

AGREEMENT

TO ACQUIRE THE 770-BED WESTERN REGION DETENTION FACILITY IN SAN

DIEGO, CALIFORNIA FOR $60 MILLION

* GEO GROUP INC ( GEO ) - PURCHASE EXPECTED TO BE ACCRETIVE TO

ANNUALIZED

ADJUSTED EBITDA

* GEO GROUP INC ( GEO ) - TO USE PROCEEDS TO PAY OFF $300 MILLION IN

FLOATING RATE DEBT

Source text:

Further company coverage:

;))

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More
Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More
Nov 11, 2024
Aramark ( ARMK ) shares are trading higher after the company reported fourth-quarter results and raised quarterly dividend. Revenue grew 5% year-over-year (Organic revenue: +7%) to $4.42 billion, missing the consensus of $4.46 billion. Revenues were driven by strong volume growth across both segments, with pricing stabilizing due to inflation trends, especially in Education. FSS United States saw revenue growth...
Imaging Centers Operator RadNet Q3 Earnings: Strong Q3 Performance On Positive Trends, Raises Annual Outlook
Imaging Centers Operator RadNet Q3 Earnings: Strong Q3 Performance On Positive Trends, Raises Annual Outlook
Nov 11, 2024
On Sunday, RadNet, Inc. ( RDNT ) reported revenue of $461.1 million for the third quarter of 2024, beating the consensus of $437.88 million. Revenue from the Digital Health reportable segment increased 34.3% to $16.4 million, partly due to a $2.2 million increase in AI Revenue, which climbed to $5.1 million during the third quarter. The increase was mainly due...
Arch Biopartners Begins Patient Dosing in Canada in Phase II Trial For LSALT Peptide
Arch Biopartners Begins Patient Dosing in Canada in Phase II Trial For LSALT Peptide
Nov 11, 2024
08:03 AM EST, 11/11/2024 (MT Newswires) -- Arch Biopartners ( ACHFF ) says patient recruitment and dosing have begun in Canada for the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The clinical team at the University of Calgary has dosed the first patient recruited for the study. The University...
Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo
Zai Lab, Argenx Receive Chinese Approval for Neuromuscular Drug Vyvgart Hytrulo
Nov 11, 2024
08:03 AM EST, 11/11/2024 (MT Newswires) -- Zai Lab ( ZLAB ) and argenx (ARGX) said Monday that China's National Medical Products Administration has approved Vyvgart Hytrulo to treat chronic inflammatory demyelinating polyneuropathy, a neuromuscular disorder, in adult patients. The companies said the approval is supported by trial data from a subgroup analysis of Chinese participants which showed a 69%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved